nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2D6—Lomustine—brain cancer	0.125	0.218	CbGbCtD
Ropivacaine—CYP1A2—Carmustine—brain cancer	0.123	0.216	CbGbCtD
Ropivacaine—CYP2D6—Hydroxyurea—brain cancer	0.0946	0.166	CbGbCtD
Ropivacaine—CYP3A4—Temozolomide—brain cancer	0.0933	0.163	CbGbCtD
Ropivacaine—CYP3A4—Lomustine—brain cancer	0.0794	0.139	CbGbCtD
Ropivacaine—CYP1A2—Etoposide—brain cancer	0.0366	0.0641	CbGbCtD
Ropivacaine—SCN8A—cerebellar cortex—brain cancer	0.0228	0.159	CbGeAlD
Ropivacaine—CYP3A4—Etoposide—brain cancer	0.0192	0.0336	CbGbCtD
Ropivacaine—SCN8A—hindbrain—brain cancer	0.00626	0.0436	CbGeAlD
Ropivacaine—SCN10A—ganglion—brain cancer	0.00552	0.0384	CbGeAlD
Ropivacaine—SCN1A—hindbrain—brain cancer	0.00473	0.0329	CbGeAlD
Ropivacaine—SCN2A—hindbrain—brain cancer	0.00434	0.0302	CbGeAlD
Ropivacaine—SCN8A—brainstem—brain cancer	0.00359	0.025	CbGeAlD
Ropivacaine—SCN8A—telencephalon—brain cancer	0.00318	0.0222	CbGeAlD
Ropivacaine—SCN1A—brainstem—brain cancer	0.00271	0.0189	CbGeAlD
Ropivacaine—SCN2A—brainstem—brain cancer	0.00249	0.0173	CbGeAlD
Ropivacaine—SCN1A—telencephalon—brain cancer	0.00241	0.0168	CbGeAlD
Ropivacaine—SCN9A—pituitary gland—brain cancer	0.00228	0.0159	CbGeAlD
Ropivacaine—SCN8A—spinal cord—brain cancer	0.00223	0.0155	CbGeAlD
Ropivacaine—SCN2A—telencephalon—brain cancer	0.00221	0.0154	CbGeAlD
Ropivacaine—SCN10A—telencephalon—brain cancer	0.00213	0.0148	CbGeAlD
Ropivacaine—Lidocaine—EGFR—brain cancer	0.00208	0.523	CrCbGaD
Ropivacaine—SCN4A—pituitary gland—brain cancer	0.00203	0.0141	CbGeAlD
Ropivacaine—SCN9A—midbrain—brain cancer	0.00201	0.014	CbGeAlD
Ropivacaine—SCN8A—endocrine gland—brain cancer	0.00201	0.014	CbGeAlD
Ropivacaine—SCN8A—head—brain cancer	0.00198	0.0138	CbGeAlD
Ropivacaine—SCN9A—spinal cord—brain cancer	0.00196	0.0136	CbGeAlD
Ropivacaine—SCN3A—telencephalon—brain cancer	0.00194	0.0135	CbGeAlD
Ropivacaine—Lidocaine—CYP2C9—brain cancer	0.0019	0.477	CrCbGaD
Ropivacaine—SCN1A—medulla oblongata—brain cancer	0.00189	0.0132	CbGeAlD
Ropivacaine—SCN8A—central nervous system—brain cancer	0.00181	0.0126	CbGeAlD
Ropivacaine—SCN2A—pituitary gland—brain cancer	0.0018	0.0125	CbGeAlD
Ropivacaine—SCN8A—cerebellum—brain cancer	0.00177	0.0123	CbGeAlD
Ropivacaine—SCN2A—medulla oblongata—brain cancer	0.00174	0.0121	CbGeAlD
Ropivacaine—SCN10A—pituitary gland—brain cancer	0.00173	0.0121	CbGeAlD
Ropivacaine—SCN1A—midbrain—brain cancer	0.00173	0.012	CbGeAlD
Ropivacaine—SCN1A—spinal cord—brain cancer	0.00169	0.0117	CbGeAlD
Ropivacaine—SCN2A—midbrain—brain cancer	0.00159	0.011	CbGeAlD
Ropivacaine—SCN3A—pituitary gland—brain cancer	0.00158	0.011	CbGeAlD
Ropivacaine—SCN4A—head—brain cancer	0.00155	0.0108	CbGeAlD
Ropivacaine—SCN2A—spinal cord—brain cancer	0.00155	0.0108	CbGeAlD
Ropivacaine—SCN3A—medulla oblongata—brain cancer	0.00153	0.0106	CbGeAlD
Ropivacaine—SCN1A—head—brain cancer	0.0015	0.0104	CbGeAlD
Ropivacaine—SCN10A—spinal cord—brain cancer	0.00149	0.0104	CbGeAlD
Ropivacaine—SCN8A—brain—brain cancer	0.00144	0.01	CbGeAlD
Ropivacaine—CYP2D6—hindbrain—brain cancer	0.00143	0.00993	CbGeAlD
Ropivacaine—SCN4A—central nervous system—brain cancer	0.00142	0.00988	CbGeAlD
Ropivacaine—SCN3A—midbrain—brain cancer	0.00139	0.0097	CbGeAlD
Ropivacaine—SCN2A—endocrine gland—brain cancer	0.00139	0.0097	CbGeAlD
Ropivacaine—SCN2A—head—brain cancer	0.00138	0.00957	CbGeAlD
Ropivacaine—SCN1A—central nervous system—brain cancer	0.00137	0.00952	CbGeAlD
Ropivacaine—SCN3A—spinal cord—brain cancer	0.00136	0.00947	CbGeAlD
Ropivacaine—SCN10A—endocrine gland—brain cancer	0.00134	0.00935	CbGeAlD
Ropivacaine—SCN1A—cerebellum—brain cancer	0.00134	0.00931	CbGeAlD
Ropivacaine—SCN10A—head—brain cancer	0.00133	0.00923	CbGeAlD
Ropivacaine—SCN9A—brain—brain cancer	0.00126	0.00879	CbGeAlD
Ropivacaine—SCN2A—central nervous system—brain cancer	0.00126	0.00874	CbGeAlD
Ropivacaine—SCN2A—cerebellum—brain cancer	0.00123	0.00854	CbGeAlD
Ropivacaine—SCN10A—central nervous system—brain cancer	0.00121	0.00843	CbGeAlD
Ropivacaine—SCN3A—head—brain cancer	0.00121	0.00841	CbGeAlD
Ropivacaine—SCN5A—head—brain cancer	0.00121	0.00839	CbGeAlD
Ropivacaine—SCN4A—brain—brain cancer	0.00113	0.00784	CbGeAlD
Ropivacaine—SCN3A—central nervous system—brain cancer	0.0011	0.00768	CbGeAlD
Ropivacaine—SCN5A—central nervous system—brain cancer	0.0011	0.00766	CbGeAlD
Ropivacaine—SCN1A—brain—brain cancer	0.00109	0.00756	CbGeAlD
Ropivacaine—SCN3A—cerebellum—brain cancer	0.00108	0.00751	CbGeAlD
Ropivacaine—Amnesia—Carmustine—brain cancer	0.00102	0.0037	CcSEcCtD
Ropivacaine—SCN2A—brain—brain cancer	0.000997	0.00694	CbGeAlD
Ropivacaine—Amnesia—Temozolomide—brain cancer	0.000986	0.00357	CcSEcCtD
Ropivacaine—SCN10A—brain—brain cancer	0.000961	0.00669	CbGeAlD
Ropivacaine—Purpura—Temozolomide—brain cancer	0.000961	0.00348	CcSEcCtD
Ropivacaine—Neuropathy—Etoposide—brain cancer	0.000959	0.00347	CcSEcCtD
Ropivacaine—Dysuria—Hydroxyurea—brain cancer	0.000959	0.00347	CcSEcCtD
Ropivacaine—Chills—Procarbazine—brain cancer	0.000951	0.00345	CcSEcCtD
Ropivacaine—Arrhythmia—Procarbazine—brain cancer	0.000947	0.00343	CcSEcCtD
Ropivacaine—Body temperature increased—Lomustine—brain cancer	0.000938	0.0034	CcSEcCtD
Ropivacaine—Drowsiness—Hydroxyurea—brain cancer	0.000914	0.00331	CcSEcCtD
Ropivacaine—Affect lability—Temozolomide—brain cancer	0.000912	0.0033	CcSEcCtD
Ropivacaine—Tension—Procarbazine—brain cancer	0.000906	0.00328	CcSEcCtD
Ropivacaine—Nervousness—Procarbazine—brain cancer	0.000896	0.00325	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000896	0.00325	CcSEcCtD
Ropivacaine—Mood swings—Temozolomide—brain cancer	0.000878	0.00318	CcSEcCtD
Ropivacaine—SCN3A—brain—brain cancer	0.000876	0.0061	CbGeAlD
Ropivacaine—SCN5A—brain—brain cancer	0.000874	0.00608	CbGeAlD
Ropivacaine—Hypokalaemia—Carmustine—brain cancer	0.000873	0.00316	CcSEcCtD
Ropivacaine—Tremor—Procarbazine—brain cancer	0.000865	0.00313	CcSEcCtD
Ropivacaine—Phlebitis—Etoposide—brain cancer	0.000861	0.00312	CcSEcCtD
Ropivacaine—Anaemia—Procarbazine—brain cancer	0.000853	0.00309	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000852	0.00309	CcSEcCtD
Ropivacaine—Hypokalaemia—Temozolomide—brain cancer	0.000843	0.00305	CcSEcCtD
Ropivacaine—Breast disorder—Temozolomide—brain cancer	0.000837	0.00303	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000834	0.00302	CcSEcCtD
Ropivacaine—Syncope—Procarbazine—brain cancer	0.000828	0.003	CcSEcCtD
Ropivacaine—CYP2D6—brainstem—brain cancer	0.000818	0.00569	CbGeAlD
Ropivacaine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000817	0.00296	CcSEcCtD
Ropivacaine—Hallucination—Hydroxyurea—brain cancer	0.000816	0.00296	CcSEcCtD
Ropivacaine—CYP2B6—gonad—brain cancer	0.000816	0.00567	CbGeAlD
Ropivacaine—Loss of consciousness—Procarbazine—brain cancer	0.000811	0.00294	CcSEcCtD
Ropivacaine—Abdominal distension—Temozolomide—brain cancer	0.000806	0.00292	CcSEcCtD
Ropivacaine—Cough—Procarbazine—brain cancer	0.000805	0.00292	CcSEcCtD
Ropivacaine—Convulsion—Procarbazine—brain cancer	0.0008	0.0029	CcSEcCtD
Ropivacaine—Hypertension—Procarbazine—brain cancer	0.000797	0.00289	CcSEcCtD
Ropivacaine—Arthralgia—Procarbazine—brain cancer	0.000786	0.00285	CcSEcCtD
Ropivacaine—Myalgia—Procarbazine—brain cancer	0.000786	0.00285	CcSEcCtD
Ropivacaine—Anxiety—Procarbazine—brain cancer	0.000783	0.00284	CcSEcCtD
Ropivacaine—Sweating increased—Temozolomide—brain cancer	0.00078	0.00283	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Etoposide—brain cancer	0.000766	0.00277	CcSEcCtD
Ropivacaine—Confusional state—Procarbazine—brain cancer	0.00076	0.00275	CcSEcCtD
Ropivacaine—Vomiting—Lomustine—brain cancer	0.000754	0.00273	CcSEcCtD
Ropivacaine—Dysuria—Temozolomide—brain cancer	0.000749	0.00271	CcSEcCtD
Ropivacaine—Infection—Procarbazine—brain cancer	0.000748	0.00271	CcSEcCtD
Ropivacaine—Hyperglycaemia—Carmustine—brain cancer	0.000748	0.00271	CcSEcCtD
Ropivacaine—Shock—Procarbazine—brain cancer	0.000741	0.00268	CcSEcCtD
Ropivacaine—Thrombocytopenia—Procarbazine—brain cancer	0.000738	0.00267	CcSEcCtD
Ropivacaine—Depression—Carmustine—brain cancer	0.000737	0.00267	CcSEcCtD
Ropivacaine—Chills—Hydroxyurea—brain cancer	0.000736	0.00267	CcSEcCtD
Ropivacaine—Tachycardia—Procarbazine—brain cancer	0.000735	0.00266	CcSEcCtD
Ropivacaine—Hyperhidrosis—Procarbazine—brain cancer	0.000728	0.00264	CcSEcCtD
Ropivacaine—CYP2D6—telencephalon—brain cancer	0.000726	0.00505	CbGeAlD
Ropivacaine—Neuropathy peripheral—Carmustine—brain cancer	0.000724	0.00262	CcSEcCtD
Ropivacaine—Hyperglycaemia—Temozolomide—brain cancer	0.000722	0.00262	CcSEcCtD
Ropivacaine—Urinary tract infection—Carmustine—brain cancer	0.000718	0.0026	CcSEcCtD
Ropivacaine—Erythema—Hydroxyurea—brain cancer	0.000714	0.00259	CcSEcCtD
Ropivacaine—Depression—Temozolomide—brain cancer	0.000712	0.00258	CcSEcCtD
Ropivacaine—Cardiac arrest—Etoposide—brain cancer	0.000705	0.00255	CcSEcCtD
Ropivacaine—Nausea—Lomustine—brain cancer	0.000705	0.00255	CcSEcCtD
Ropivacaine—Hypotension—Procarbazine—brain cancer	0.000704	0.00255	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Temozolomide—brain cancer	0.0007	0.00254	CcSEcCtD
Ropivacaine—Urinary tract infection—Temozolomide—brain cancer	0.000694	0.00251	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000686	0.00249	CcSEcCtD
Ropivacaine—Insomnia—Procarbazine—brain cancer	0.000681	0.00247	CcSEcCtD
Ropivacaine—Paraesthesia—Procarbazine—brain cancer	0.000676	0.00245	CcSEcCtD
Ropivacaine—Somnolence—Procarbazine—brain cancer	0.00067	0.00243	CcSEcCtD
Ropivacaine—Cramp muscle—Etoposide—brain cancer	0.000668	0.00242	CcSEcCtD
Ropivacaine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000663	0.0024	CcSEcCtD
Ropivacaine—Anaemia—Hydroxyurea—brain cancer	0.00066	0.00239	CcSEcCtD
Ropivacaine—Hallucination—Carmustine—brain cancer	0.00066	0.00239	CcSEcCtD
Ropivacaine—Hypoaesthesia—Carmustine—brain cancer	0.00066	0.00239	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000654	0.00237	CcSEcCtD
Ropivacaine—Oedema peripheral—Carmustine—brain cancer	0.000653	0.00237	CcSEcCtD
Ropivacaine—Malaise—Hydroxyurea—brain cancer	0.000644	0.00233	CcSEcCtD
Ropivacaine—Constipation—Procarbazine—brain cancer	0.000644	0.00233	CcSEcCtD
Ropivacaine—Pain—Procarbazine—brain cancer	0.000644	0.00233	CcSEcCtD
Ropivacaine—CYP1A2—endocrine gland—brain cancer	0.000643	0.00447	CbGeAlD
Ropivacaine—Hallucination—Temozolomide—brain cancer	0.000638	0.00231	CcSEcCtD
Ropivacaine—Hypoaesthesia—Temozolomide—brain cancer	0.000638	0.00231	CcSEcCtD
Ropivacaine—Urinary tract disorder—Temozolomide—brain cancer	0.000633	0.00229	CcSEcCtD
Ropivacaine—Oedema peripheral—Temozolomide—brain cancer	0.000632	0.00229	CcSEcCtD
Ropivacaine—Bronchospasm—Etoposide—brain cancer	0.00063	0.00228	CcSEcCtD
Ropivacaine—Urethral disorder—Temozolomide—brain cancer	0.000628	0.00228	CcSEcCtD
Ropivacaine—Sweating increased—Etoposide—brain cancer	0.000624	0.00226	CcSEcCtD
Ropivacaine—Feeling abnormal—Procarbazine—brain cancer	0.000621	0.00225	CcSEcCtD
Ropivacaine—Convulsion—Hydroxyurea—brain cancer	0.000619	0.00224	CcSEcCtD
Ropivacaine—CYP2B6—endocrine gland—brain cancer	0.000616	0.00429	CbGeAlD
Ropivacaine—Gastrointestinal pain—Procarbazine—brain cancer	0.000616	0.00223	CcSEcCtD
Ropivacaine—CYP2B6—head—brain cancer	0.000608	0.00423	CbGeAlD
Ropivacaine—Discomfort—Hydroxyurea—brain cancer	0.000601	0.00218	CcSEcCtD
Ropivacaine—Urticaria—Procarbazine—brain cancer	0.000598	0.00217	CcSEcCtD
Ropivacaine—Tinnitus—Temozolomide—brain cancer	0.000598	0.00216	CcSEcCtD
Ropivacaine—Abdominal pain—Procarbazine—brain cancer	0.000595	0.00216	CcSEcCtD
Ropivacaine—Body temperature increased—Procarbazine—brain cancer	0.000595	0.00216	CcSEcCtD
Ropivacaine—Cardiac disorder—Temozolomide—brain cancer	0.000595	0.00215	CcSEcCtD
Ropivacaine—Arrhythmia—Carmustine—brain cancer	0.000593	0.00215	CcSEcCtD
Ropivacaine—Mental disorder—Carmustine—brain cancer	0.000581	0.0021	CcSEcCtD
Ropivacaine—Infection—Hydroxyurea—brain cancer	0.000579	0.0021	CcSEcCtD
Ropivacaine—Erythema—Carmustine—brain cancer	0.000577	0.00209	CcSEcCtD
Ropivacaine—Chills—Temozolomide—brain cancer	0.000575	0.00208	CcSEcCtD
Ropivacaine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000571	0.00207	CcSEcCtD
Ropivacaine—Skin disorder—Hydroxyurea—brain cancer	0.000566	0.00205	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Etoposide—brain cancer	0.000563	0.00204	CcSEcCtD
Ropivacaine—Mental disorder—Temozolomide—brain cancer	0.000562	0.00203	CcSEcCtD
Ropivacaine—Myocardial infarction—Etoposide—brain cancer	0.00056	0.00203	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Etoposide—brain cancer	0.00056	0.00203	CcSEcCtD
Ropivacaine—Back pain—Carmustine—brain cancer	0.000559	0.00202	CcSEcCtD
Ropivacaine—Erythema—Temozolomide—brain cancer	0.000558	0.00202	CcSEcCtD
Ropivacaine—Jaundice—Etoposide—brain cancer	0.000557	0.00202	CcSEcCtD
Ropivacaine—CYP2B6—central nervous system—brain cancer	0.000555	0.00386	CbGeAlD
Ropivacaine—Hypersensitivity—Procarbazine—brain cancer	0.000555	0.00201	CcSEcCtD
Ropivacaine—Vision blurred—Carmustine—brain cancer	0.000544	0.00197	CcSEcCtD
Ropivacaine—Tremor—Carmustine—brain cancer	0.000541	0.00196	CcSEcCtD
Ropivacaine—Asthenia—Procarbazine—brain cancer	0.00054	0.00196	CcSEcCtD
Ropivacaine—Back pain—Temozolomide—brain cancer	0.00054	0.00196	CcSEcCtD
Ropivacaine—Anaemia—Carmustine—brain cancer	0.000534	0.00193	CcSEcCtD
Ropivacaine—Pruritus—Procarbazine—brain cancer	0.000533	0.00193	CcSEcCtD
Ropivacaine—Agitation—Carmustine—brain cancer	0.000531	0.00192	CcSEcCtD
Ropivacaine—Vision blurred—Temozolomide—brain cancer	0.000526	0.0019	CcSEcCtD
Ropivacaine—Tremor—Temozolomide—brain cancer	0.000523	0.00189	CcSEcCtD
Ropivacaine—Dyspnoea—Hydroxyurea—brain cancer	0.00052	0.00188	CcSEcCtD
Ropivacaine—Somnolence—Hydroxyurea—brain cancer	0.000518	0.00188	CcSEcCtD
Ropivacaine—Ill-defined disorder—Temozolomide—brain cancer	0.000518	0.00188	CcSEcCtD
Ropivacaine—Anaemia—Temozolomide—brain cancer	0.000516	0.00187	CcSEcCtD
Ropivacaine—Diarrhoea—Procarbazine—brain cancer	0.000515	0.00187	CcSEcCtD
Ropivacaine—Dyspepsia—Hydroxyurea—brain cancer	0.000513	0.00186	CcSEcCtD
Ropivacaine—Agitation—Temozolomide—brain cancer	0.000513	0.00186	CcSEcCtD
Ropivacaine—Hypoaesthesia—Etoposide—brain cancer	0.00051	0.00185	CcSEcCtD
Ropivacaine—Angioedema—Temozolomide—brain cancer	0.00051	0.00185	CcSEcCtD
Ropivacaine—Urinary tract disorder—Etoposide—brain cancer	0.000507	0.00183	CcSEcCtD
Ropivacaine—Malaise—Temozolomide—brain cancer	0.000503	0.00182	CcSEcCtD
Ropivacaine—Urethral disorder—Etoposide—brain cancer	0.000503	0.00182	CcSEcCtD
Ropivacaine—Vertigo—Temozolomide—brain cancer	0.000501	0.00182	CcSEcCtD
Ropivacaine—Convulsion—Carmustine—brain cancer	0.0005	0.00181	CcSEcCtD
Ropivacaine—Hypertension—Carmustine—brain cancer	0.000499	0.00181	CcSEcCtD
Ropivacaine—Constipation—Hydroxyurea—brain cancer	0.000499	0.00181	CcSEcCtD
Ropivacaine—Pain—Hydroxyurea—brain cancer	0.000499	0.00181	CcSEcCtD
Ropivacaine—Dizziness—Procarbazine—brain cancer	0.000498	0.0018	CcSEcCtD
Ropivacaine—Myalgia—Carmustine—brain cancer	0.000492	0.00178	CcSEcCtD
Ropivacaine—Chest pain—Carmustine—brain cancer	0.000492	0.00178	CcSEcCtD
Ropivacaine—Anxiety—Carmustine—brain cancer	0.00049	0.00177	CcSEcCtD
Ropivacaine—Cough—Temozolomide—brain cancer	0.000487	0.00176	CcSEcCtD
Ropivacaine—Convulsion—Temozolomide—brain cancer	0.000483	0.00175	CcSEcCtD
Ropivacaine—Hypertension—Temozolomide—brain cancer	0.000482	0.00175	CcSEcCtD
Ropivacaine—Feeling abnormal—Hydroxyurea—brain cancer	0.00048	0.00174	CcSEcCtD
Ropivacaine—Vomiting—Procarbazine—brain cancer	0.000479	0.00173	CcSEcCtD
Ropivacaine—Cardiac disorder—Etoposide—brain cancer	0.000476	0.00172	CcSEcCtD
Ropivacaine—Confusional state—Carmustine—brain cancer	0.000475	0.00172	CcSEcCtD
Ropivacaine—Myalgia—Temozolomide—brain cancer	0.000475	0.00172	CcSEcCtD
Ropivacaine—Arthralgia—Temozolomide—brain cancer	0.000475	0.00172	CcSEcCtD
Ropivacaine—Rash—Procarbazine—brain cancer	0.000475	0.00172	CcSEcCtD
Ropivacaine—Dermatitis—Procarbazine—brain cancer	0.000475	0.00172	CcSEcCtD
Ropivacaine—Anxiety—Temozolomide—brain cancer	0.000473	0.00171	CcSEcCtD
Ropivacaine—Headache—Procarbazine—brain cancer	0.000472	0.00171	CcSEcCtD
Ropivacaine—Discomfort—Temozolomide—brain cancer	0.000469	0.0017	CcSEcCtD
Ropivacaine—Infection—Carmustine—brain cancer	0.000468	0.0017	CcSEcCtD
Ropivacaine—CYP3A4—endocrine gland—brain cancer	0.000465	0.00324	CbGeAlD
Ropivacaine—Thrombocytopenia—Carmustine—brain cancer	0.000461	0.00167	CcSEcCtD
Ropivacaine—Body temperature increased—Hydroxyurea—brain cancer	0.000461	0.00167	CcSEcCtD
Ropivacaine—Chills—Etoposide—brain cancer	0.00046	0.00167	CcSEcCtD
Ropivacaine—Tachycardia—Carmustine—brain cancer	0.00046	0.00167	CcSEcCtD
Ropivacaine—Confusional state—Temozolomide—brain cancer	0.000459	0.00166	CcSEcCtD
Ropivacaine—CYP2D6—endocrine gland—brain cancer	0.000458	0.00319	CbGeAlD
Ropivacaine—Anaphylactic shock—Temozolomide—brain cancer	0.000455	0.00165	CcSEcCtD
Ropivacaine—Infection—Temozolomide—brain cancer	0.000452	0.00164	CcSEcCtD
Ropivacaine—CYP2D6—head—brain cancer	0.000452	0.00315	CbGeAlD
Ropivacaine—Nausea—Procarbazine—brain cancer	0.000447	0.00162	CcSEcCtD
Ropivacaine—Thrombocytopenia—Temozolomide—brain cancer	0.000446	0.00162	CcSEcCtD
Ropivacaine—Skin disorder—Temozolomide—brain cancer	0.000442	0.0016	CcSEcCtD
Ropivacaine—CYP2B6—brain—brain cancer	0.000441	0.00307	CbGeAlD
Ropivacaine—Hypotension—Carmustine—brain cancer	0.00044	0.0016	CcSEcCtD
Ropivacaine—Hyperhidrosis—Temozolomide—brain cancer	0.00044	0.00159	CcSEcCtD
Ropivacaine—Back pain—Etoposide—brain cancer	0.000432	0.00156	CcSEcCtD
Ropivacaine—Hypersensitivity—Hydroxyurea—brain cancer	0.00043	0.00156	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000429	0.00156	CcSEcCtD
Ropivacaine—Muscle spasms—Etoposide—brain cancer	0.000429	0.00155	CcSEcCtD
Ropivacaine—Insomnia—Carmustine—brain cancer	0.000426	0.00154	CcSEcCtD
Ropivacaine—Paraesthesia—Carmustine—brain cancer	0.000423	0.00153	CcSEcCtD
Ropivacaine—Dyspnoea—Carmustine—brain cancer	0.00042	0.00152	CcSEcCtD
Ropivacaine—CYP3A4—central nervous system—brain cancer	0.000419	0.00292	CbGeAlD
Ropivacaine—Somnolence—Carmustine—brain cancer	0.000419	0.00152	CcSEcCtD
Ropivacaine—Asthenia—Hydroxyurea—brain cancer	0.000418	0.00152	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000415	0.0015	CcSEcCtD
Ropivacaine—Ill-defined disorder—Etoposide—brain cancer	0.000414	0.0015	CcSEcCtD
Ropivacaine—Anaemia—Etoposide—brain cancer	0.000413	0.00149	CcSEcCtD
Ropivacaine—CYP2D6—central nervous system—brain cancer	0.000413	0.00287	CbGeAlD
Ropivacaine—Insomnia—Temozolomide—brain cancer	0.000412	0.00149	CcSEcCtD
Ropivacaine—Paraesthesia—Temozolomide—brain cancer	0.000409	0.00148	CcSEcCtD
Ropivacaine—Dyspnoea—Temozolomide—brain cancer	0.000406	0.00147	CcSEcCtD
Ropivacaine—Somnolence—Temozolomide—brain cancer	0.000405	0.00147	CcSEcCtD
Ropivacaine—CYP2D6—cerebellum—brain cancer	0.000403	0.00281	CbGeAlD
Ropivacaine—Pain—Carmustine—brain cancer	0.000403	0.00146	CcSEcCtD
Ropivacaine—Constipation—Carmustine—brain cancer	0.000403	0.00146	CcSEcCtD
Ropivacaine—Malaise—Etoposide—brain cancer	0.000403	0.00146	CcSEcCtD
Ropivacaine—Vertigo—Etoposide—brain cancer	0.000401	0.00145	CcSEcCtD
Ropivacaine—Dyspepsia—Temozolomide—brain cancer	0.000401	0.00145	CcSEcCtD
Ropivacaine—Diarrhoea—Hydroxyurea—brain cancer	0.000399	0.00144	CcSEcCtD
Ropivacaine—Loss of consciousness—Etoposide—brain cancer	0.000392	0.00142	CcSEcCtD
Ropivacaine—Cough—Etoposide—brain cancer	0.00039	0.00141	CcSEcCtD
Ropivacaine—Pain—Temozolomide—brain cancer	0.000389	0.00141	CcSEcCtD
Ropivacaine—Constipation—Temozolomide—brain cancer	0.000389	0.00141	CcSEcCtD
Ropivacaine—Feeling abnormal—Carmustine—brain cancer	0.000388	0.00141	CcSEcCtD
Ropivacaine—Convulsion—Etoposide—brain cancer	0.000387	0.0014	CcSEcCtD
Ropivacaine—Hypertension—Etoposide—brain cancer	0.000386	0.0014	CcSEcCtD
Ropivacaine—Dizziness—Hydroxyurea—brain cancer	0.000386	0.0014	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Carmustine—brain cancer	0.000385	0.0014	CcSEcCtD
Ropivacaine—Chest pain—Etoposide—brain cancer	0.00038	0.00138	CcSEcCtD
Ropivacaine—Discomfort—Etoposide—brain cancer	0.000376	0.00136	CcSEcCtD
Ropivacaine—Feeling abnormal—Temozolomide—brain cancer	0.000375	0.00136	CcSEcCtD
Ropivacaine—Abdominal pain—Carmustine—brain cancer	0.000373	0.00135	CcSEcCtD
Ropivacaine—Body temperature increased—Carmustine—brain cancer	0.000373	0.00135	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Temozolomide—brain cancer	0.000372	0.00135	CcSEcCtD
Ropivacaine—Vomiting—Hydroxyurea—brain cancer	0.000371	0.00134	CcSEcCtD
Ropivacaine—Rash—Hydroxyurea—brain cancer	0.000368	0.00133	CcSEcCtD
Ropivacaine—Confusional state—Etoposide—brain cancer	0.000367	0.00133	CcSEcCtD
Ropivacaine—Dermatitis—Hydroxyurea—brain cancer	0.000367	0.00133	CcSEcCtD
Ropivacaine—Headache—Hydroxyurea—brain cancer	0.000365	0.00132	CcSEcCtD
Ropivacaine—Anaphylactic shock—Etoposide—brain cancer	0.000364	0.00132	CcSEcCtD
Ropivacaine—Infection—Etoposide—brain cancer	0.000362	0.00131	CcSEcCtD
Ropivacaine—Urticaria—Temozolomide—brain cancer	0.000362	0.00131	CcSEcCtD
Ropivacaine—Body temperature increased—Temozolomide—brain cancer	0.00036	0.0013	CcSEcCtD
Ropivacaine—Abdominal pain—Temozolomide—brain cancer	0.00036	0.0013	CcSEcCtD
Ropivacaine—Thrombocytopenia—Etoposide—brain cancer	0.000357	0.00129	CcSEcCtD
Ropivacaine—Tachycardia—Etoposide—brain cancer	0.000356	0.00129	CcSEcCtD
Ropivacaine—Skin disorder—Etoposide—brain cancer	0.000354	0.00128	CcSEcCtD
Ropivacaine—Hyperhidrosis—Etoposide—brain cancer	0.000352	0.00128	CcSEcCtD
Ropivacaine—Hypersensitivity—Carmustine—brain cancer	0.000347	0.00126	CcSEcCtD
Ropivacaine—Nausea—Hydroxyurea—brain cancer	0.000346	0.00125	CcSEcCtD
Ropivacaine—Hypotension—Etoposide—brain cancer	0.000341	0.00123	CcSEcCtD
Ropivacaine—Asthenia—Carmustine—brain cancer	0.000338	0.00122	CcSEcCtD
Ropivacaine—Hypersensitivity—Temozolomide—brain cancer	0.000336	0.00122	CcSEcCtD
Ropivacaine—CYP2D6—brain—brain cancer	0.000328	0.00228	CbGeAlD
Ropivacaine—Paraesthesia—Etoposide—brain cancer	0.000327	0.00119	CcSEcCtD
Ropivacaine—Asthenia—Temozolomide—brain cancer	0.000327	0.00118	CcSEcCtD
Ropivacaine—Dyspnoea—Etoposide—brain cancer	0.000325	0.00118	CcSEcCtD
Ropivacaine—Somnolence—Etoposide—brain cancer	0.000324	0.00117	CcSEcCtD
Ropivacaine—Diarrhoea—Carmustine—brain cancer	0.000322	0.00117	CcSEcCtD
Ropivacaine—Pruritus—Temozolomide—brain cancer	0.000322	0.00117	CcSEcCtD
Ropivacaine—Dizziness—Carmustine—brain cancer	0.000312	0.00113	CcSEcCtD
Ropivacaine—Constipation—Etoposide—brain cancer	0.000312	0.00113	CcSEcCtD
Ropivacaine—Pain—Etoposide—brain cancer	0.000312	0.00113	CcSEcCtD
Ropivacaine—Diarrhoea—Temozolomide—brain cancer	0.000312	0.00113	CcSEcCtD
Ropivacaine—Dizziness—Temozolomide—brain cancer	0.000301	0.00109	CcSEcCtD
Ropivacaine—Feeling abnormal—Etoposide—brain cancer	0.0003	0.00109	CcSEcCtD
Ropivacaine—Vomiting—Carmustine—brain cancer	0.0003	0.00109	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Etoposide—brain cancer	0.000298	0.00108	CcSEcCtD
Ropivacaine—Rash—Carmustine—brain cancer	0.000297	0.00108	CcSEcCtD
Ropivacaine—Dermatitis—Carmustine—brain cancer	0.000297	0.00108	CcSEcCtD
Ropivacaine—Headache—Carmustine—brain cancer	0.000295	0.00107	CcSEcCtD
Ropivacaine—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.000293	0.0586	CbGpPWpGaD
Ropivacaine—Vomiting—Temozolomide—brain cancer	0.00029	0.00105	CcSEcCtD
Ropivacaine—Urticaria—Etoposide—brain cancer	0.00029	0.00105	CcSEcCtD
Ropivacaine—Abdominal pain—Etoposide—brain cancer	0.000288	0.00104	CcSEcCtD
Ropivacaine—Body temperature increased—Etoposide—brain cancer	0.000288	0.00104	CcSEcCtD
Ropivacaine—Rash—Temozolomide—brain cancer	0.000287	0.00104	CcSEcCtD
Ropivacaine—Dermatitis—Temozolomide—brain cancer	0.000287	0.00104	CcSEcCtD
Ropivacaine—Headache—Temozolomide—brain cancer	0.000285	0.00103	CcSEcCtD
Ropivacaine—Nausea—Carmustine—brain cancer	0.00028	0.00101	CcSEcCtD
Ropivacaine—Nausea—Temozolomide—brain cancer	0.000271	0.00098	CcSEcCtD
Ropivacaine—Hypersensitivity—Etoposide—brain cancer	0.000269	0.000973	CcSEcCtD
Ropivacaine—Asthenia—Etoposide—brain cancer	0.000261	0.000947	CcSEcCtD
Ropivacaine—Pruritus—Etoposide—brain cancer	0.000258	0.000934	CcSEcCtD
Ropivacaine—Diarrhoea—Etoposide—brain cancer	0.000249	0.000903	CcSEcCtD
Ropivacaine—Dizziness—Etoposide—brain cancer	0.000241	0.000873	CcSEcCtD
Ropivacaine—Vomiting—Etoposide—brain cancer	0.000232	0.000839	CcSEcCtD
Ropivacaine—Rash—Etoposide—brain cancer	0.00023	0.000832	CcSEcCtD
Ropivacaine—Dermatitis—Etoposide—brain cancer	0.00023	0.000832	CcSEcCtD
Ropivacaine—Headache—Etoposide—brain cancer	0.000228	0.000827	CcSEcCtD
Ropivacaine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000222	0.0445	CbGpPWpGaD
Ropivacaine—Nausea—Etoposide—brain cancer	0.000216	0.000784	CcSEcCtD
Ropivacaine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000203	0.0407	CbGpPWpGaD
Ropivacaine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000202	0.0405	CbGpPWpGaD
Ropivacaine—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000181	0.0363	CbGpPWpGaD
Ropivacaine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000126	0.0253	CbGpPWpGaD
Ropivacaine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000125	0.0249	CbGpPWpGaD
Ropivacaine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000121	0.0243	CbGpPWpGaD
Ropivacaine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000119	0.0238	CbGpPWpGaD
Ropivacaine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000107	0.0214	CbGpPWpGaD
Ropivacaine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000103	0.0206	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—HES5—brain cancer	8.5e-05	0.017	CbGpPWpGaD
Ropivacaine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	8.24e-05	0.0165	CbGpPWpGaD
Ropivacaine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	7.93e-05	0.0159	CbGpPWpGaD
Ropivacaine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	7.53e-05	0.0151	CbGpPWpGaD
Ropivacaine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	7.43e-05	0.0149	CbGpPWpGaD
Ropivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	6.98e-05	0.014	CbGpPWpGaD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—brain cancer	6.35e-05	0.0127	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	6.1e-05	0.0122	CbGpPWpGaD
Ropivacaine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	5.66e-05	0.0113	CbGpPWpGaD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	5.39e-05	0.0108	CbGpPWpGaD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	5.23e-05	0.0105	CbGpPWpGaD
Ropivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	5.17e-05	0.0103	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	5.13e-05	0.0103	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—TRPC6—brain cancer	4.82e-05	0.00966	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	4.43e-05	0.00888	CbGpPWpGaD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	4.38e-05	0.00877	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	4.24e-05	0.0085	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—TRPC6—brain cancer	3.9e-05	0.00782	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—TRPC6—brain cancer	3.73e-05	0.00748	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—ESR2—brain cancer	3.62e-05	0.00725	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	3.59e-05	0.0072	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—TRPC6—brain cancer	3.59e-05	0.00718	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—TRPC6—brain cancer	3.59e-05	0.00718	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—TRPC6—brain cancer	3.46e-05	0.00693	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—TRPC6—brain cancer	3.46e-05	0.00693	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TRPC6—brain cancer	3.44e-05	0.0069	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	3.42e-05	0.00686	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	3.38e-05	0.00677	CbGpPWpGaD
Ropivacaine—SCN8A—L1CAM interactions—EGFR—brain cancer	3.27e-05	0.00655	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	3.24e-05	0.0065	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	3.2e-05	0.00641	CbGpPWpGaD
Ropivacaine—CYP3A4—Irinotecan Pathway—APC—brain cancer	2.91e-05	0.00582	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—HES1—brain cancer	2.81e-05	0.00563	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TRPC6—brain cancer	2.78e-05	0.00558	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	2.77e-05	0.00556	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TRPC6—brain cancer	2.66e-05	0.00534	CbGpPWpGaD
Ropivacaine—SCN9A—L1CAM interactions—EGFR—brain cancer	2.64e-05	0.0053	CbGpPWpGaD
Ropivacaine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	2.58e-05	0.00516	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TRPC6—brain cancer	2.56e-05	0.00513	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TRPC6—brain cancer	2.56e-05	0.00513	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—EGFR—brain cancer	2.53e-05	0.00507	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TRPC6—brain cancer	2.47e-05	0.00494	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TRPC6—brain cancer	2.47e-05	0.00494	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—TRPC6—brain cancer	2.43e-05	0.00487	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—EGFR—brain cancer	2.43e-05	0.00487	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—EGFR—brain cancer	2.43e-05	0.00487	CbGpPWpGaD
Ropivacaine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	2.37e-05	0.00474	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—EGFR—brain cancer	2.34e-05	0.00469	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—EGFR—brain cancer	2.34e-05	0.00469	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	2.25e-05	0.00452	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	2.22e-05	0.00445	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—HES1—brain cancer	2.22e-05	0.00444	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	1.97e-05	0.00395	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	1.91e-05	0.00383	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	1.88e-05	0.00377	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—HES1—brain cancer	1.79e-05	0.00359	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—ERBB2—brain cancer	1.78e-05	0.00357	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—CDK4—brain cancer	1.74e-05	0.00349	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TRPC6—brain cancer	1.73e-05	0.00347	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—HES1—brain cancer	1.72e-05	0.00344	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—HES1—brain cancer	1.65e-05	0.0033	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—HES1—brain cancer	1.65e-05	0.0033	CbGpPWpGaD
Ropivacaine—SCN5A—L1CAM interactions—EGFR—brain cancer	1.65e-05	0.0033	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HES1—brain cancer	1.59e-05	0.00318	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HES1—brain cancer	1.59e-05	0.00318	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	1.47e-05	0.00295	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	1.45e-05	0.00291	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—ERBB2—brain cancer	1.44e-05	0.00289	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	1.41e-05	0.00282	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—CDK4—brain cancer	1.41e-05	0.00282	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—ERBB2—brain cancer	1.38e-05	0.00276	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—VEGFA—brain cancer	1.37e-05	0.00275	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CDK4—brain cancer	1.35e-05	0.0027	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—ERBB2—brain cancer	1.32e-05	0.00265	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—ERBB2—brain cancer	1.32e-05	0.00265	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CDK4—brain cancer	1.29e-05	0.00259	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CDK4—brain cancer	1.29e-05	0.00259	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—RELA—brain cancer	1.28e-05	0.00256	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—ERBB2—brain cancer	1.28e-05	0.00256	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—ERBB2—brain cancer	1.28e-05	0.00256	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—ERBB2—brain cancer	1.27e-05	0.00255	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CDK4—brain cancer	1.25e-05	0.0025	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CDK4—brain cancer	1.25e-05	0.0025	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—brain cancer	1.24e-05	0.00249	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—EGFR—brain cancer	1.24e-05	0.00247	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	1.14e-05	0.00228	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HES1—brain cancer	1.12e-05	0.00224	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—CTNNB1—brain cancer	1.11e-05	0.00223	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—VEGFA—brain cancer	1.11e-05	0.00222	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—VEGFA—brain cancer	1.06e-05	0.00213	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—RELA—brain cancer	1.03e-05	0.00207	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—ERBB2—brain cancer	1.03e-05	0.00206	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	1.02e-05	0.00205	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—VEGFA—brain cancer	1.02e-05	0.00204	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—VEGFA—brain cancer	1.02e-05	0.00204	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—EGFR—brain cancer	9.99e-06	0.002	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—RELA—brain cancer	9.9e-06	0.00198	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—ERBB2—brain cancer	9.84e-06	0.00197	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—VEGFA—brain cancer	9.84e-06	0.00197	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—VEGFA—brain cancer	9.84e-06	0.00197	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—VEGFA—brain cancer	9.79e-06	0.00196	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—STAT3—brain cancer	9.7e-06	0.00194	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—EGFR—brain cancer	9.55e-06	0.00191	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—RELA—brain cancer	9.51e-06	0.00191	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—RELA—brain cancer	9.51e-06	0.00191	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ERBB2—brain cancer	9.45e-06	0.00189	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—ERBB2—brain cancer	9.45e-06	0.00189	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—EGFR—brain cancer	9.18e-06	0.00184	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—EGFR—brain cancer	9.18e-06	0.00184	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—RELA—brain cancer	9.17e-06	0.00184	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—RELA—brain cancer	9.17e-06	0.00184	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ERBB2—brain cancer	9.11e-06	0.00183	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—ERBB2—brain cancer	9.11e-06	0.00183	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—CTNNB1—brain cancer	9e-06	0.0018	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—ERBB2—brain cancer	8.98e-06	0.0018	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—EGFR—brain cancer	8.85e-06	0.00177	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—EGFR—brain cancer	8.85e-06	0.00177	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EGFR—brain cancer	8.81e-06	0.00177	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CDK4—brain cancer	8.77e-06	0.00176	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	8.7e-06	0.00174	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CTNNB1—brain cancer	8.61e-06	0.00172	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CTNNB1—brain cancer	8.27e-06	0.00166	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CTNNB1—brain cancer	8.27e-06	0.00166	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	8e-06	0.0016	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CTNNB1—brain cancer	7.97e-06	0.0016	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CTNNB1—brain cancer	7.97e-06	0.0016	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—VEGFA—brain cancer	7.92e-06	0.00159	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—STAT3—brain cancer	7.84e-06	0.00157	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	7.83e-06	0.00157	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	7.83e-06	0.00157	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—VEGFA—brain cancer	7.58e-06	0.00152	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—STAT3—brain cancer	7.5e-06	0.0015	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.33e-06	0.00147	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—brain cancer	7.28e-06	0.00146	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—brain cancer	7.28e-06	0.00146	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—STAT3—brain cancer	7.21e-06	0.00144	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—STAT3—brain cancer	7.21e-06	0.00144	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—brain cancer	7.13e-06	0.00143	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—brain cancer	7.02e-06	0.00141	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—brain cancer	7.02e-06	0.00141	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—STAT3—brain cancer	6.95e-06	0.00139	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—STAT3—brain cancer	6.95e-06	0.00139	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—brain cancer	6.92e-06	0.00139	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—brain cancer	6.82e-06	0.00137	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—brain cancer	6.55e-06	0.00131	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—brain cancer	6.55e-06	0.00131	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—RELA—brain cancer	6.45e-06	0.00129	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ERBB2—brain cancer	6.41e-06	0.00128	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—brain cancer	6.32e-06	0.00127	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—brain cancer	6.32e-06	0.00127	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—brain cancer	6.22e-06	0.00125	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CTNNB1—brain cancer	5.61e-06	0.00112	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP2C9—brain cancer	5.55e-06	0.00111	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.36e-06	0.00107	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—brain cancer	4.93e-06	0.000989	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—STAT3—brain cancer	4.89e-06	0.000979	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—BSG—brain cancer	4.72e-06	0.000945	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—brain cancer	4.44e-06	0.00089	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—IDH1—brain cancer	4.05e-06	0.000812	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP2C9—brain cancer	3.85e-06	0.000772	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—BSG—brain cancer	3.28e-06	0.000657	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP2C9—brain cancer	3.27e-06	0.000654	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ENO2—brain cancer	3.21e-06	0.000642	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—IDH1—brain cancer	2.82e-06	0.000565	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—BSG—brain cancer	2.78e-06	0.000556	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP2C9—brain cancer	2.52e-06	0.000505	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—IDH1—brain cancer	2.39e-06	0.000478	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ENO2—brain cancer	2.23e-06	0.000446	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—BSG—brain cancer	2.14e-06	0.000429	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.94e-06	0.000389	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ENO2—brain cancer	1.89e-06	0.000378	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—IDH1—brain cancer	1.84e-06	0.000369	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CG—brain cancer	1.47e-06	0.000295	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ENO2—brain cancer	1.46e-06	0.000292	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CG—brain cancer	1.02e-06	0.000205	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CG—brain cancer	8.66e-07	0.000173	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CG—brain cancer	6.68e-07	0.000134	CbGpPWpGaD
